Cargando…
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
Gastric cancer (GC) is the third leading cause of cancer mortality worldwide. Although surgical resection is a potentially curative approach for localized cases of GC, most cases of GC are diagnosed in an advanced, non-curable stage and the response to traditional chemotherapy is limited. Fortunatel...
Autores principales: | Riquelme, Ismael, Saavedra, Kathleen, Espinoza, Jaime A., Weber, Helga, García, Patricia, Nervi, Bruno, Garrido, Marcelo, Corvalán, Alejandro H., Roa, Juan Carlos, Bizama, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694793/ https://www.ncbi.nlm.nih.gov/pubmed/26267324 |
Ejemplares similares
-
Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice
por: Weber, Helga, et al.
Publicado: (2015) -
MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer
por: Sandoval-Bórquez, Alejandra, et al.
Publicado: (2017) -
Correction to: MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer
por: Sandoval-Bórquez, Alejandra, et al.
Publicado: (2021) -
Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer
por: Weber, Helga, et al.
Publicado: (2017) -
Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer
por: García, Patricia, et al.
Publicado: (2020)